![George Kassiotis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
George Kassiotis
Chief Executive Officer at Omega Navigation Enterprises, Inc.
George Kassiotis active positions
Companies | Position | Start | End |
---|---|---|---|
Omega Navigation Enterprises, Inc.
![]() Omega Navigation Enterprises, Inc. Marine ShippingTransportation Omega Navigation Enterprises, Inc. operates as an investment holding company, which engages in the provision of marine transportation services through the ownership and operation of double hull product tankers. It focuses on seaborne transportation of refined petroleum products. The firm also provides technical, operating and administrative services to the joint venture companies. The company was founded on February 28, 2005 and is headquartered in Athens, Greece. | Director/Board Member | 27/02/2005 | - |
Chief Executive Officer | 27/02/2005 | - | |
President | 27/02/2005 | - |
Career history of George Kassiotis
Former positions of George Kassiotis
Companies | Position | Start | End |
---|---|---|---|
Ervaxx Ltd.
![]() Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | Founder | - | - |
Training of George Kassiotis
Université Paris 1 Panthéon-Sorbonne | Undergraduate Degree |
University of London | Graduate Degree |
Statistics
International
United Kingdom | 3 |
Greece | 2 |
France | 2 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
President | 1 |
Sectoral
Consumer Services | 3 |
Transportation | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Omega Navigation Enterprises, Inc.
![]() Omega Navigation Enterprises, Inc. Marine ShippingTransportation Omega Navigation Enterprises, Inc. operates as an investment holding company, which engages in the provision of marine transportation services through the ownership and operation of double hull product tankers. It focuses on seaborne transportation of refined petroleum products. The firm also provides technical, operating and administrative services to the joint venture companies. The company was founded on February 28, 2005 and is headquartered in Athens, Greece. | Transportation |
Ervaxx Ltd.
![]() Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | Health Technology |
- Stock Market
- Insiders
- George Kassiotis
- Experience